Kessler Topaz Meltzer & Check, LLP is investigating Alnylam Pharmaceuticals, Inc. for potential securities violations following significant stock losses after disappointing financial results.

Kessler Topaz Meltzer & Check, LLP alerts CarMax investors of an amended class action lawsuit regarding securities fraud, encouraging affected shareholders to take action before the deadline.

A class action lawsuit has been filed against Charter Communications by Kessler Topaz Meltzer & Check LLP alleging securities fraud. Investors affected should take action now.

Kessler Topaz Meltzer & Check, LLP has filed a securities class action against Geron Corporation, alleging misleading statements about growth and product performance.

Kessler Topaz Meltzer & Check, LLP has filed a class action lawsuit against Neumora Therapeutics over alleged securities fraud. The deadline for lead plaintiff applications is April 7, 2025.

Kessler Topaz Meltzer & Check, LLP has initiated a class-action lawsuit against The Trade Desk, Inc. due to alleged misstatements affecting investors between May 2024 and February 2025.

Kessler Topaz Meltzer & Check, LLP is urging investors of Monolithic Power Systems who faced losses to connect with the firm regarding a class action lawsuit.

Kessler Topaz Meltzer & Check, LLP alerts Applied Therapeutics, Inc. investors of the impending class action lawsuit filing deadline on February 18, 2025.

Kessler Topaz Meltzer & Check, LLP has initiated a class action lawsuit against Kyverna Therapeutics, alleging misrepresentation in IPO materials. Investors are called to action.